In a note revealed on Monday morning, The "Neutral" rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) shares was kept by Analysts at Cantor Fitzgerald, who now has a $5 target price per share on the stock. Based on an average trading volume of 3,400,352 shares, the days-to-cover ratio is presently 1.3 days. Arrowhead Pharma (NASDAQ:ARWR) has a market cap of $390.92 Million and the number of outstanding shares have been calculated 75.76 Million. $3.75's average target is -27.18% below currents $5.15 stock price.
Analysts are speculating a 6.59% move, based on the high target price ($5.5) for the shares that is set to reach in the next 12 months.
However out of 4 analysts 1 suggest Arrowhead Pharma (NASDAQ:ARWR) a Strong Buy, 1 suggested Buy, 3 Hold and 0 Sell, while 0 analysts recommend the stock a Strong Sell. A sell rating on the other hand would be a recommendation to sell the security if now held, and avoid purchasing it on the open market. On Thursday, September 14 the stock rating was maintained by Piper Jaffray with "Hold". In order to determine directional movement, the 50-day and 200-day moving averages for Arrowhead Pharmaceuticals, Inc. Arrowhead Pharma (NASDAQ:ARWR)'s price distance from 52-week high is -21.33 and from 52-week low is 273.94. The stock carved out a 52-week low down at $1.42. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages.
Arrowhead Pharma (NASDAQ:ARWR)'s shares slipped -2.57% in the past week and soared 5.36% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 188.59% while its year to date performance is at 44.29%.
While taking a glance at financials, we can look at a number of key indicators.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) last issued its earnings results on Tuesday, December 12th.
While having a peek at profitability ratios Arrowhead Pharma (NASDAQ:ARWR) has trailing twelve month gross margin at 0%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%. The beta factor is 0.71.Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. The stock's price to sales ratio for trailing twelve months is 4.06 and price to book ratio for the most recent quarter is 3.16, whereas price to cash per share for the most recent quarter are N/A.
The company's quick ratio for most recent quarter is 3.6 along with current ratio for most recent quarter of 3.6. However the company's price to cash per share for most recent quarter stands at 0.87. Overall, 2.23 Million shares exchanged hands versus its average volume of $2.43 Million. The analysts, on average, are forecasting a $4.83 price target, but the stock is already up 263.38% from its recent lows.
Analysts have suggested a mean rating of 2.20 on the shares. William Blair also issued estimates for Arrowhead Pharmaceuticals' Q3 2018 earnings at ($0.20) EPS, Q4 2018 earnings at ($0.21) EPS, FY2018 earnings at ($0.80) EPS, Q1 2019 earnings at ($0.22) EPS, Q2 2019 earnings at ($0.23) EPS, Q3 2019 earnings at ($0.24) EPS, Q4 2019 earnings at ($0.25) EPS, FY2019 earnings at ($0.94) EPS and FY2020 earnings at ($1.21) EPS.
The stock of HRG Group, Inc. and Arrowhead Pharmaceuticals, Inc. were two of the most active stocks on Monday.
The stock now shows its YTD (Year to Date) performance of 40.22 percent, whereas its Weekly performance stands at -9.63%. In the past 13-year record, this ratio went down as low as 4.04 and as high as 4936. Academic research has shown that stocks close to their 52 week highs tend to outperform. Latest trading price was 10.11% upbeat to its 50-day moving average and above 66.89% to its 200-day moving average. The business had revenue of $8.71 million during the quarter, compared to analysts' expectations of $7.32 million. equities research analysts forecast that Arrowhead Pharmaceuticals will post -0.67 EPS for the current year.
The Average True Range (ATR) is an indicator that measures volatility, it was developed by J. Welles Wilder. Relative strength index (RSI-14) for Telefonica Sa (NYSE:TEF) is at 34.81. For example, if a stock's beta is 1.2, it's theoretically 20% more volatile than the market.
Weighing in at 8lb 10oz, Cass is the fourth child of Coleen and Wayne Rooney and is the youngest sibling of Kai, Klay and Kit . The 31-year-old is seen lying in bed with the baby wrapped up on her chest in the black and white snap, posted on Instagram.
Bloombergsen Inc decreased its stake in Aon Plc (AON) by 0.41% based on its latest 2017Q3 regulatory filing with the SEC. CARP DANIEL A also sold $2.13 million worth of Texas Instruments Incorporated (NASDAQ: TXN ) on Friday, October 27.
The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). Neville Rodie & Shaw Inc sold 14,188 shares as the company's stock declined 7.66% while stock markets rallied.
Veteran South Africa batsman Hashim Amla has admitted that he has been "very impressed" with Aiden Markram's style of captaincy. Of course, people want to talk me, they can talk about me. "But I don't believe it will spin that much in England", he said.
However, at one point, in the middle of the day, the price touched a high of $1.22 before it finally returned some of the gains. The fund owned 418,650 shares of the shipping company's stock after buying an additional 86,300 shares during the quarter.
The fund owned 40,161 shares of the semiconductor company's stock after purchasing an additional 13,269 shares during the period. Hancock Holding Company decreased Pool Corp (NASDAQ:POOL) stake by 37,751 shares to 189,449 valued at $20.49 million in 2017Q3.
The Vols appeared to have put the game out of reach a handful of times, highlighted by a 13-2 run midway through the second half. However, Tennessee's Lamonte Turner kept the team hot from deep range as he hit a 3-pointer to give the Vols an 11-7 lead.
Ethiopia's government has always been accused of arresting journalists and opposition leaders. His stepping down from power is unprecedented in the vast East African country.
Nokia (NYSE: NOK) Beats Street's Expectations
Zacks Investment Research raised shares of Nokia Oyj from a "sell" rating to a "hold" rating in a report on Tuesday, February 6th. Current volume in a stock, relative to prior volume, shows if interest is higher or lower in a stock than it was before.
Untimely rains in Maharashtra damage crops in 1 lakh ha
On February 11 and 12, the state had hailstorm in its Marathwada and Vidarbha region affecting 16 districts and 1279 villages. Vidarbha and Marathwada region witnessed heavy hailstorm activity and unseasonal rains on February 11 and 12.
Paypal (PYPL) Earns Buy Rating from Citigroup
PayPal Holdings, Inc.'s Average Earnings Estimate for the current quarter is $0.54, according to consensus of 42 analysts. At the close of regular trading, its last week's stock price volatility was 6.71% which for the month reaches 8.84%.
Army officer picked up for questioning
Last week, Group Captain Arun Marwah of Indian Air Force was arrested on the charge of espionage from Delhi. Sources claimed that the Army officer has been trapped in a honey-trap case.
Wholesale prices fall to six-month low
The wholesale price index (WPI Index) eased to a six-month low of 2.84 % in January mainly due to cheaper food articles. This is different from the consumer price index-based inflation, which reflects price changes in the retail market.